Spots Global Cancer Trial Database for kidney neoplasms
Every month we try and update this database with for kidney neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer | NCT00095108 | Melanoma Kidney Neoplasm... Metastases | Recombinant Hum... | 18 Years - | ZymoGenetics | |
| Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer | NCT00282048 | Kidney Neoplasm... Carcinoma, Rena... | AG-013736 (axit... | 18 Years - | Pfizer | |
| Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. | NCT01398306 | Carcinoma Carcinoma, Rena... Neuroendocrine ... Carcinoid Tumor Pancreatic Isle... | Blood sampling ... | 18 Years - | University Medical Center Groningen | |
| Cabozantinib for Advanced Urothelial Cancer | NCT01688999 | Urothelial Carc... Urethral Neopla... Urinary Bladder... Kidney Neoplasm... | Cabozantinib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma | NCT02689167 | Kidney Neoplasm... Metastatic Rena... | Sunitinib | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma | NCT02386111 | Carcinoma, Rena... Kidney Diseases Kidney Neoplasm... Urogenital Neop... Urologic Diseas... Urologic Neopla... Neoplasms Neoplasms by Hi... Clear-cell Meta... | Combination of ... | 18 Years - | Celldex Therapeutics | |
| Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours | NCT04040530 | Renal Cell Carc... Quality of Life | CT-guided cryoa... Partial nephrec... | 18 Years - | Region of Southern Denmark | |
| Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) | NCT05665361 | Advanced Clear ... Papillary Renal... | Sasanlimab Palbocicilib | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours | NCT04040530 | Renal Cell Carc... Quality of Life | CT-guided cryoa... Partial nephrec... | 18 Years - | Region of Southern Denmark | |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties | NCT00980317 | Kidney Neoplasm... Renal Insuffici... Renal Replaceme... | Restored Kidney... | 20 Years - | Tokushukai Medical Group | |
| Renal Cell Carcinoma Microenvironment Discovery Project | NCT04005183 | Renal Cell Carc... | 18 Years - | University Health Network, Toronto | ||
| Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus) | NCT00651482 | Kidney Neoplasm... Kidney (Renal C... | Everolimus Bevacizumab | 18 Years - | Stanford University | |
| The Effect of Pre-treatment Biopsy for Non-neoplastic Renal Disease vs no Biopsy on Estimated Glomerular Filtration Rate in Patients With Small Renal Mass: a Single-center, Single-blinded, Randomized, Parallel Group Clinical Trial | NCT02841020 | Kidney Neoplasm... | Additional biop... | 18 Years - 85 Years | University of Virginia | |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) | NCT02228954 | Clear-cell Meta... Kidney Neoplasm... | Molecular imagi... | 18 Years - | Radboud University Medical Center | |
| LPN in Patients With High-complex Renal Tumors | NCT04933604 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Oncology Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | laparoscopic pa... Laparoscopic ra... | 18 Years - 80 Years | Samsun Liv Hospital | |
| IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) | NCT02228954 | Clear-cell Meta... Kidney Neoplasm... | Molecular imagi... | 18 Years - | Radboud University Medical Center | |
| A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India | NCT04513522 | Kidney Neoplasm... | Nivolumab Ipilimumab | 18 Years - | Bristol-Myers Squibb | |
| A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) | NCT02684006 | Renal Cell Canc... | Avelumab (MSB00... Axitinib (AG-01... Sunitinib | 18 Years - | Pfizer | |
| Tracking Renal Tumors After Cryoablation Evaluation | NCT01117779 | Kidney Neoplasm... | Cryoablation | 18 Years - | Boston Scientific Corporation | |
| Savolitinib vs. Sunitinib in MET-driven PRCC. | NCT03091192 | Carcinoma Carcinoma, Rena... Kidney Neoplasm... Urologic Neopla... Kidney Diseases Neoplasms by Si... Enzyme Inhibito... Protein Kinase ... | Savolitinib Sunitinib | 18 Years - 130 Years | AstraZeneca | |
| NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma | NCT01649180 | Renal Cell Carc... | Axitinib | 18 Years - | PrECOG, LLC. | |
| A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer | NCT00375674 | Kidney Neoplasm... | Sunitinib malat... Placebo | 18 Years - | Pfizer | |
| Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma | NCT05790122 | Carcinoma, Rena... Kidney Neoplasm... | 18 Years - 80 Years | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | ||
| Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer | NCT00091611 | Kidney Neoplasm... | IL-2 (interleuk... OKT3 Cyclophosphamid... Fludarabine Mesna | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. | NCT03943771 | Kidney Neoplasm... Carcinoma, Rena... | Anxiety, renal ... | 18 Years - | University Hospital, Bordeaux | |
| A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies | NCT04544748 | Carcinoma, Non-... Carcinoma, Rena... Melanoma | GNR-051 | 18 Years - | AO GENERIUM | |
| A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies | NCT04544748 | Carcinoma, Non-... Carcinoma, Rena... Melanoma | GNR-051 | 18 Years - | AO GENERIUM | |
| 3D Virtual Models as an Adjunct to Preoperative Surgical Planning | NCT03606044 | Kidney Neoplasm... Surgical Oncolo... | 3D-models | 18 Years - 80 Years | Innersight Labs Ltd | |
| Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer | NCT00033137 | Kidney Neoplasm... Kidney Cancer Pneumothorax FLCN Protein, H... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response | NCT02439008 | Carcinoma, Hepa... Colorectal Neop... Melanoma Kidney Neoplasm... | Blood samples c... Blood samples c... Blood samples c... Radiotherapy | 18 Years - | Centre Oscar Lambret | |
| Von Hippel-Lindau Disease Genetic Epidemiology Study | NCT00001803 | Von Hippel Lind... Kidney Neoplasm... | 13 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy | NCT01218854 | Lung Neoplasms Liver Neoplasms Kidney Neoplasm... Cancer | Needle angle me... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy | NCT02924922 | Kidney Neoplasm... | Laparoscopic pa... Robot assisted ... Conventional la... Da- Vinci Robot... Mannitol | 18 Years - | Luzerner Kantonsspital | |
| Laparoscopic Partial Nephrectomy for cT1 Tumors | NCT04213157 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Surgery--Compli... Renal Functiona... Oncology Oncology Proble... Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | 18 Years - 82 Years | Samsun Liv Hospital | ||
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. | NCT01398306 | Carcinoma Carcinoma, Rena... Neuroendocrine ... Carcinoid Tumor Pancreatic Isle... | Blood sampling ... | 18 Years - | University Medical Center Groningen | |
| Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach | NCT05218811 | Kidney Neoplasm... | Cryoablation As... | 55 Years - 65 Years | Urological Research Network, LLC | |
| Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. | NCT03943771 | Kidney Neoplasm... Carcinoma, Rena... | Anxiety, renal ... | 18 Years - | University Hospital, Bordeaux | |
| LPN in Patients With High-complex Renal Tumors | NCT04933604 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Oncology Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | laparoscopic pa... Laparoscopic ra... | 18 Years - 80 Years | Samsun Liv Hospital | |
| A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer | NCT00001570 | Kidney Neoplasm... Neoplasm Metast... | PSC 833 vinblastine | - | National Institutes of Health Clinical Center (CC) | |
| Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | NCT05068180 | Stomach Neoplas... Colonic Neoplas... Rectal Neoplasm... Sigmoid Neoplas... Liver Neoplasms Kidney Neoplasm... Urinary Bladder... Prostatic Neopl... Osteoarthropath... Fractures, Bone Gynecologic Can... | low-dose neurol... Placebo | 65 Years - 85 Years | RenJi Hospital | |
| Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) | NCT05917106 | Carcinoma Renal Cell Carc... RCC Kidney Neoplasm... Kidney Cancer | - | Jinling Hospital, China | ||
| 3D Virtual Models as an Adjunct to Preoperative Surgical Planning | NCT03606044 | Kidney Neoplasm... Surgical Oncolo... | 3D-models | 18 Years - 80 Years | Innersight Labs Ltd | |
| MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers | NCT06126159 | Kidney Neoplasm... | multiparametric... | 20 Years - | Chang Gung Memorial Hospital | |
| Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma | NCT05790122 | Carcinoma, Rena... Kidney Neoplasm... | 18 Years - 80 Years | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | ||
| A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma | NCT02386111 | Carcinoma, Rena... Kidney Diseases Kidney Neoplasm... Urogenital Neop... Urologic Diseas... Urologic Neopla... Neoplasms Neoplasms by Hi... Clear-cell Meta... | Combination of ... | 18 Years - | Celldex Therapeutics | |
| A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) | NCT02684006 | Renal Cell Canc... | Avelumab (MSB00... Axitinib (AG-01... Sunitinib | 18 Years - | Pfizer | |
| Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors | NCT00507884 | Kidney Neoplasm... | 3 Tesla MRI Sca... | - | M.D. Anderson Cancer Center | |
| Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer | NCT00678392 | Kidney Neoplasm... | Axitinib (AG-01... Sorafenib | 18 Years - | Pfizer | |
| Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | NCT00101608 | Transitional Ce... Bladder Neoplas... Kidney Neoplasm... Ureter Neoplasm... Bladder Cancer Neoplasm, Bladd... | vinflunine | 18 Years - | Bristol-Myers Squibb | |
| Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | NCT05068180 | Stomach Neoplas... Colonic Neoplas... Rectal Neoplasm... Sigmoid Neoplas... Liver Neoplasms Kidney Neoplasm... Urinary Bladder... Prostatic Neopl... Osteoarthropath... Fractures, Bone Gynecologic Can... | low-dose neurol... Placebo | 65 Years - 85 Years | RenJi Hospital | |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties | NCT00980317 | Kidney Neoplasm... Renal Insuffici... Renal Replaceme... | Restored Kidney... | 20 Years - | Tokushukai Medical Group | |
| Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries | NCT04669366 | Kidney Neoplasm... | sunitinib axitinib | 18 Years - 99 Years | Pfizer | |
| EPO906 Therapy in Patients With Advanced Kidney Cancer | NCT00035243 | Kidney Neoplasm... | epothilone b | 18 Years - 85 Years | Novartis | |
| Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma | NCT00065468 | Carcinoma, Rena... Kidney Neoplasm... | Interferon Alfa CCI-779 Interferon Alfa... | 18 Years - | Pfizer | |
| A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma | NCT00226980 | Kidney Neoplasm... | Thalidomide Capecitabine | 18 Years - | Stanford University | |
| The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy | NCT01413607 | Kidney Neoplasm... | Quill knotless ... 2-0 absorbable ... | - | Nova Scotia Health Authority | |
| Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) | NCT05935748 | ccRCC Clear Cell Rena... Kidney Cancer Kidney Neoplasm... Renal Cancer Renal Neoplasms Recurrent Renal... Metastatic Rena... Refractory Rena... Advanced Renal ... Carcinoma Neoplasms Carcinoma, Rena... Neoplasms, Glan... Neoplasm by His... Adenocarcinoma Urologic Neopla... Urogenital Neop... Neoplasms by Si... Kidney Diseases Urologic Diseas... | NKT2152 palbociclib sasanlimab | 18 Years - | NiKang Therapeutics, Inc. | |
| Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy | NCT02924922 | Kidney Neoplasm... | Laparoscopic pa... Robot assisted ... Conventional la... Da- Vinci Robot... Mannitol | 18 Years - | Luzerner Kantonsspital | |
| CT Versus CEUS Findings of Complex Cystic Renal Lesions | NCT01159717 | Kidney Neoplasm... Computed Tomogr... Ultrasonography Contrast Media | 18 Years - | University Hospital, Basel, Switzerland | ||
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment | NCT02301117 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma | NCT04300140 | Clear Cell Rena... | Batiraxcept Cabozantinib (C... Nivolumab | 18 Years - | Aravive, Inc. | |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors | NCT00221728 | Kidney Neoplasm... | Radiofrequency conservative su... | 18 Years - | University Hospital, Bordeaux | |
| The Association of Marital Status With Kidney Cancer Surgery Morbidity | NCT05526599 | Marriage Kidney Neoplasm... Surgery-Complic... Cohort Studies | 18 Years - | Beijing Tsinghua Chang Gung Hospital | ||
| A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) | NCT03729245 | Renal Cell Carc... Metastatic Rena... | bempegaldesleuk... sunitinib nivolumab cabozantinib | 18 Years - | Nektar Therapeutics | |
| LPN in Patients With High-complex Renal Tumors | NCT04933604 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Oncology Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | laparoscopic pa... Laparoscopic ra... | 18 Years - 80 Years | Samsun Liv Hospital | |
| Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy | NCT01892059 | Kidney Neoplasm... Renal Cell Carc... | Segmental arter... Main renal arte... | 20 Years - 70 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib | NCT03129724 | Kidney Neoplasm... | 18 Years - | University Hospital, Strasbourg, France | ||
| Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer | NCT00095108 | Melanoma Kidney Neoplasm... Metastases | Recombinant Hum... | 18 Years - | ZymoGenetics | |
| The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy | NCT05432232 | Renal Cancer Tumor, Solid Kidney Cancer Tumor Tumor, Benign Kidney Neoplasm... | HistoSonics Inv... | 18 Years - | HistoSonics, Inc. | |
| Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI | NCT00537056 | Kidney Neoplasm... Carcinoma, Rena... Kidney (Renal C... | FDG PET CT DCE MRI F-18 Fluoro-deo... Gadolinium-DTPA Sunitinib | 18 Years - | Stanford University | |
| Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) | NCT05665361 | Advanced Clear ... Papillary Renal... | Sasanlimab Palbocicilib | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American | NCT05184504 | Kidney Neoplasm... | Observational s... | 18 Years - | Latin American Cooperative Oncology Group | |
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma | NCT04300140 | Clear Cell Rena... | Batiraxcept Cabozantinib (C... Nivolumab | 18 Years - | Aravive, Inc. | |
| A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma | NCT00226980 | Kidney Neoplasm... | Thalidomide Capecitabine | 18 Years - | Stanford University | |
| LPN in Patients With High-complex Renal Tumors | NCT04933604 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Oncology Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | laparoscopic pa... Laparoscopic ra... | 18 Years - 80 Years | Samsun Liv Hospital | |
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | NCT00753415 | Non-Small Cell ... Breast Cancer Melanoma Upper GI Tract ... Colon Carcinoma Renal Cell Carc... Bladder Carcino... Prostate Cancer | V935 V934-EP | 18 Years - | Merck Sharp & Dohme LLC | |
| Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma | NCT00076011 | Kidney Neoplasm... | Vascular Endoth... | 18 Years - | Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
